188 related articles for article (PubMed ID: 29213987)
1. Neuroimaging of HIV-associated neurocognitive disorders.
Haziot MEJ; Barbosa Junior SP; Vidal JE; de Oliveira FTM; de Oliveira ACP
Dement Neuropsychol; 2015; 9(4):380-384. PubMed ID: 29213987
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated neurocognitive disorders: Five new things.
Rumbaugh JA; Tyor W
Neurol Clin Pract; 2015 Jun; 5(3):224-231. PubMed ID: 26124979
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review.
Moschopoulos CD; Stanitsa E; Protopapas K; Kavatha D; Papageorgiou SG; Antoniadou A; Papadopoulos A
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672778
[TBL] [Abstract][Full Text] [Related]
4. HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
Mohamed AA; Oduor C; Kinyanjui D
BMC Neurol; 2020 Jul; 20(1):280. PubMed ID: 32664858
[TBL] [Abstract][Full Text] [Related]
5. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
[TBL] [Abstract][Full Text] [Related]
6. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
[TBL] [Abstract][Full Text] [Related]
7. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
8. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
9. White matter damage, neuroinflammation, and neuronal integrity in HAND.
Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
[TBL] [Abstract][Full Text] [Related]
10. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
Nyundo AA
PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
[TBL] [Abstract][Full Text] [Related]
11. HIV-associated neurological disorders: a guide to pharmacotherapy.
Tan IL; McArthur JC
CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
[TBL] [Abstract][Full Text] [Related]
12. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of HIV-associated neurocognitive disorder (HAND) in Turkey and assessment of Addenbrooke's Cognitive Examination Revised (ACE-R) test as a screening tool.
Korten V; Ay U; Harı E; Tigen Tükenmez E; Gencer S; Akça Kalem S; Demirtaş Tatlıdede A; Gürvit İH
HIV Med; 2021 Jan; 22(1):60-66. PubMed ID: 32964651
[TBL] [Abstract][Full Text] [Related]
14. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder.
Forno G; Henríquez F; Ceballos ME; Gonzalez M; Schröder J; Toro P
Neuropsychologia; 2020 Sep; 146():107545. PubMed ID: 32593722
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
Mugendi AG; Kubo MN; Nyamu DG; Mwaniki LM; Wahome SK; Haberer JE
Neurol Res Int; 2019; 2019():5173289. PubMed ID: 31781391
[TBL] [Abstract][Full Text] [Related]
16. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
[TBL] [Abstract][Full Text] [Related]
17. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
19. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
